Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Drugs|October 25, 2002
Cholesterol absorption inhibitors for the treatment of hypercholesterolaemiaThomas Sudhop, Klaus von BergmannArzneimittel-Forschung|September 19, 2003
[Pleiotrophic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors)]Michael Igel, Thomas Sudhop, Klaus von BergmannPharmacology & Therapeutics|March 2, 2005
Sterol transporters: targets of natural sterols and new lipid lowering drugsThomas Sudhop, Dieter Lütjohann, Klaus von BergmannThe American Journal of Cardiology|July 5, 2005
Cholesterol and plant sterol absorption: recent insightsKlaus von Bergmann, Thomas Sudhop, Dieter LütjohannJournal of Clinical Pharmacology|August 7, 2002
Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatinMichael Igel, Thomas Sudhop, Klaus von BergmannMetabolism: Clinical and Experimental|December 19, 2002
Serum plant sterols as a potential risk factor for coronary heart diseaseThomas Sudhop, Britta M Gottwald, Klaus von BergmannMolecular Nutrition & Food Research|February 11, 2018
Cholesterol Absorption and Synthesis in Vegetarians and OmnivoresDieter Lütjohann, Sven Meyer, Klaus von Bergmann, et al.The Journal of Steroid Biochemistry and Molecular Biology|April 10, 2016
The value of surrogate markers to monitor cholesterol absorption, synthesis and bioconversion to bile acids under lipid lowering therapiesFrans Stellaard, Klaus von Bergmann, Thomas Sudhop, et al.Journal of Lipid Research|January 9, 2003
Efficiency of intestinal cholesterol absorption in humans is not related to apoE phenotypeKlaus Von Bergmann, Dieter Lütjohann, Bernhard Lindenthal, et al.Journal of Lipid Research|February 4, 2003
Comparison of the intestinal uptake of cholesterol, plant sterols, and stanols in miceMichael Igel, Uwe Giesa, Dieter Lutjohann, et al.Pageof 7